Alex Flint, Eisai’s Neurology Marketing Director, is responsible for the commercialization of Eisai Canada’s Neurology product portfolio including treatments for Alzheimer’s Disease, Sleep/Wake Disorder and Epilepsy. Prior to Alex’s transition to his current role in 2021, he was Senior Director, Medical and Regulatory Affairs at Eisai Canada, responsible for Medical Affairs, Regulatory Affairs, Product Safety, Quality Assurance, and Compliance across both the Neurology and Oncology portfolio.
